Development and validation of a UHPLC-HRMS-QTOF method for the detection of 132 New Psychoactive Substances and synthetic opioids, including fentanyl, in Dried Blood Spots.

[1]  A. Salomone,et al.  Seizures of New Psychoactive Substances on the Italian territory during the COVID-19 pandemic , 2021, Forensic Science International.

[2]  M. Thevis,et al.  Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? - Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings. , 2021, Drug testing and analysis.

[3]  C. Previderè,et al.  A comparison between two different dried blood substrates in determination of psychoactive substances in postmortem samples , 2021, Forensic Toxicology.

[4]  H. Sumnall,et al.  New psychoactive substances: a review and updates , 2020, Therapeutic advances in psychopharmacology.

[5]  H. H. See,et al.  A review of recent advances in microsampling techniques of biological fluids for therapeutic drug monitoring. , 2020, Journal of chromatography. A.

[6]  P. Xiang,et al.  Screening of Synthetic Cathinones and Metabolites in Dried Blood Spots by UPLC-MS-MS. , 2020, Journal of analytical toxicology.

[7]  E. Alladio,et al.  Effective validation of chromatographic analytical methods: The illustrative case of androgenic steroids. , 2020, Talanta.

[8]  Eugenio Alladio,et al.  Experimental and statistical protocol for the effective validation of chromatographic analytical methods , 2020, MethodsX.

[9]  A. Kopylov,et al.  Dried Blood Spot in Laboratory: Directions and Prospects , 2020, Diagnostics.

[10]  R. Bruno,et al.  New psychoactive substances: challenges for drug surveillance, control, and public health responses , 2019, The Lancet.

[11]  I. Binswanger,et al.  The United States opioid epidemic. , 2019, Seminars in perinatology.

[12]  Christophe Stove,et al.  Official International Association for Therapeutic Drug Monitoring and Toxicology guideline: Development and Validation of Dried Blood Spot-based Methods for Therapeutic Drug Monitoring. , 2019, Therapeutic drug monitoring.

[13]  H. Maurer,et al.  Relevance of published blood concentrations of new psychoactive substance for rational case interpretation , 2018, WIREs Forensic Science.

[14]  Ken-ichi Yoshida,et al.  Experimental Study on the Postmortem Redistribution of the Substituted Phenethylamine, 25B‐NBOMe , 2018, Journal of forensic sciences.

[15]  M. Graw,et al.  MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations. , 2018, Forensic science international.

[16]  Mário J Dias,et al.  Dried blood spots combined to an UPLC–MS/MS method for the simultaneous determination of drugs of abuse in forensic toxicology , 2018, Journal of pharmaceutical and biomedical analysis.

[17]  Brigitte Desharnais,et al.  Procedure for the Selection and Validation of a Calibration Model II-Theoretical Basis. , 2017, Journal of analytical toxicology.

[18]  S. Aarde,et al.  Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration. , 2016, Current topics in behavioral neurosciences.

[19]  A. Salomone,et al.  Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples , 2016, Analytical and Bioanalytical Chemistry.

[20]  D. Touw,et al.  Dried blood spot analysis; facing new challenges , 2015 .

[21]  D. Tracy,et al.  Legal highs: staying on top of the flood of novel psychoactive substances , 2015, Therapeutic advances in psychopharmacology.

[22]  W. Lambert,et al.  Spot them in the spot: analysis of abused substances using dried blood spots. , 2014, Bioanalysis.

[23]  Huidong Gu,et al.  Selecting the correct weighting factors for linear and quadratic calibration curves with least-squares regression algorithm in bioanalytical LC-MS/MS assays and impacts of using incorrect weighting factors on curve stability, data quality, and assay performance. , 2014, Analytical chemistry.

[24]  W. H. Hannon,et al.  Overview of the History and Applications of Dried Blood Samples , 2014 .

[25]  J. Henion,et al.  Fully-automated approach for online dried blood spot extraction and bioanalysis by two-dimensional-liquid chromatography coupled with high-resolution quadrupole time-of-flight mass spectrometry. , 2014, Analytical chemistry.

[26]  Kayla N. Ellefsen,et al.  Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.

[27]  Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology. , 2013, Journal of analytical toxicology.

[28]  W. Lambert,et al.  Dried blood spots in toxicology: from the cradle to the grave? , 2012, Critical reviews in toxicology.

[29]  A. Deep,et al.  DRY BLOOD SPOT TECHNIQUE: A REVIEW Review Article , 2012 .

[30]  V. Pirro,et al.  Fast screening of 88 pharmaceutical drugs and metabolites in whole blood by ultrahigh-performance liquid chromatography–tandem mass spectrometry , 2012, Analytical and Bioanalytical Chemistry.

[31]  H. Sumnall,et al.  Social, policy, and public health perspectives on new psychoactive substances. , 2011, Drug testing and analysis.

[32]  C. Scriver,et al.  A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, by Robert Guthrie and Ada Susi, Pediatrics, 1963;32:318-343. , 1998, Pediatrics.

[33]  Lloyd A. Currie,et al.  Detection and quantification limits: origins and historical overview , 1997 .

[34]  Andre. Hubaux,et al.  Decision and detection limits for calibration curves , 1970 .